$SRNE Just to make clear . There are many monoclonal antibody cocktails out there in various stages. It is great for SRNE every time any of them are accepted . Sorrento's offering for MAb cocktail COVI-AMG (mAb targeting S-protein epitope, specifically D614G variant) These take quite awhile to get to the stage of acceptance. Now whether the folks at Sorrento figured out early the delta variant "D614G" was going to be big or not...that is what they targeted. sciencedirect.com/science/a...
An update to monoclonal antibody as therapeutic option against COVID-19via: Sciencedirect